A Phase 2 Study of GVAX Colon Vaccine (With Cyclophosphamide) and Pembrolizumab in Patients With Mismatch Repair-Proficient (MMR-p) Advanced Colorectal Cancer
Latest Information Update: 13 May 2022
At a glance
- Drugs Cyclophosphamide (Primary) ; Pembrolizumab (Primary) ; Tumour cell vaccine-GVAX (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Sep 2019 Status changed from active, no longer recruiting to completed.
- 19 Jan 2019 Results presented at the 2019 Gastrointestinal Cancers Symposium
- 04 Apr 2018 Status changed from recruiting to active, no longer recruiting.